Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable
The George Institute
Cardiovascular device infections
1 trial -
Fludex 1,5 mg, επικαλυμμένα με λεπτό υμένιο δισκία παρατεταμένης αποδέσμευσης., LUCIDEL 150 mg επικαλυμμένα με λεπτό υμένιο δισκία., Amlopen® 5mg καψάκια σκληρά, Inosamin 25mg, επικαλυμμένα με λεπτό υμένιο δισκία
The George Institute
Hypertension
1 trial -
Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
The George Institute
Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV
1 trial -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.
The George Institute
Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).
1 trial -
HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE
The George Institute
Rheumatoid Arthritis
1 trial -
INDOCYANINE GREEN
The George Institute
Patients with liver tumors that will undergo minimally invasive liver surgery
1 trial -
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
The George Institute
Influenza, Immunity against influenza
1 trial -
Iomeron 400 mgI/ml solution for injection
The George Institute
Thoracic neoplasm
1 trial -
KENACORT 40 mg/ml sospensione iniettabile, Suero Fisiológico Braun 0,9% disolvente para uso parenteral Cloruro de sodio, Lidocaína B. Braun 20 mg/ml solución inyectable, BUPIVACAÍNA PHYSAN 0,25% SOLUCIÓN INYECTABLE
The George Institute
TRAPEZIUS MYOFASCIAL SYNDROME IN FIBROMYALGIA PATIENTS
1 trial -
LINEZOLID, LINEZOLID
The George Institute
Sepsis
1 trial -
LIVTENCITY 200 mg film-coated tablets.
The George Institute
Transplant patients with high recurrent Epstein-Barr infection
1 trial -
Levobupivacaína Normon 5 mg/ml solución inyectable y para perfusión EFG, Inibsacain 5 mg/ml + 0,005 mg/ml solución inyectable en cartucho
The George Institute
Hip fracture
1 trial -
Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets
The George Institute
High risk atrial fibrillation patients with previous intracranial hemorrhage
1 trial -
Metformin Actavis 500 mg filmdragerad tablett
The George Institute
Polycystic ovary syndrome
1 trial -
Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule
The George Institute
lumbosacral radiculalgia
1 trial -
Mounjaro 5 mg solution for injection in pre-filled pen, Mounjaro 2.5 mg solution for injection in pre-filled pen
The George Institute
Obesity
1 trial -
Norfloxacino Sandoz 400 mg comprimidos EFG
The George Institute
Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.
1 trial -
OPDIVO 10 mg/mL concentrate for solution for infusion., CABOMETYX 20 mg film-coated tablets, CABOMETYX 40 mg film-coated tablets
The George Institute
Renal carcinoma
1 trial -
ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg sol
The George Institute
Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.
1 trial -
Ozempic 1 mg solution for injection in pre-filled pen, Dapagliflozin 10 mg film-coated tablets
The George Institute
Type 2 diabetes
1 trial -
Pentocur 1 g pulver till injektionsvätska, lösning
The George Institute
Major depressive disorder
1 trial -
Plasma rich in growth factors, -
The George Institute
Glaucoma, Dry eye disease
1 trial -
Prednisona Pensa 5 mg comprimidos EFG, Simulect 20 mg powder for solution for injection or infusion, tacrolimus cinfa 1 mg cápsulas duras EFG, Micofenolato Mofetile Accord 250 mg capsule rigide, Metilprednisolona NORMON 40 mg polvo y disolvente para solución inyectable EFG, TIMOGLOBULINA 5 mg/ml, polvo para solución para perfusión
The George Institute
Kidney Transplant
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources